Neumora Therapeutics, Inc. NMRA
0.33 USD -0.01 (-3.78%)
Regular-session close
0.32 -0.01 -4.16%
After hours · Nov 20, 7:02 PM ET
0.3011 Day range 0.3599
0.3339 52-week range 3.59
- YTD
- -81.35%
- 1 year
- -85.85%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -241.16M | -263.46M | -252.10M | -135.87M | -237.32M | |
| -236.93M | -243.79M | -235.93M | -130.90M | -237.31M | |
| -1.45 | -1.53 | -3.63 | -4.81 | -1.38 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 182.53M | 143.36M | 375.25M | 242.21M | 409.37M | |
| 191.05M | 316.97M | 496.19M | 426.23M | 429.30M | |
| 87.18M | 29.91M | 27.12M | 29.40M | 24.66M | |
| 55.01M | 1.85M | 5.23M | 8.44M | 2.05M | |
| 103.87M | 287.06M | 469.08M | -446.85M | -325.22M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -206.44M | -182.94M | -163.28M | -114.90M | -75.42M | |
| 168.52M | -70.56M | 64.39M | -168.01M | -817.00K | |
| 77.09M | 21.60M | 231.94M | 115.74M | 293.51M | |
| 218.00K | 0 | -117.00K | -511.00K | -817.00K | |
| 39.17M | -231.89M | 133.04M | -167.17M | 217.27M |
